申请人:——
公开号:US05153180A1
公开(公告)日:1992-10-06
A process for treating AIDS, which comprises administering to a patient in need therefor a pharmaceutical composition comprising a therapeutically effective amount of a compound having the formula ##STR1## wherein: R.sub.1 is an adenine, cytosine, guanine, thymidine, uracil, 5-substituted uracil, 5-substituted cytosine derivative, 2-fluoroadenine, 2.6-diaminopurine, 2-aminopurine, 6-thioguanine, or 7-deazaadenine group; R.sub.2 is H, or a OH group; R.sub.3 is a OH, O-acyl, O-palmitoyl group or phosphates (as free acid, or its alkali, ammonium or alkyl ammonium salts), or any other precursor group for the hydroxyl group; or a physiologically acceptable salt thereof. Furthermore, the present invention comprises the new compounds: 2',3'-dideoxy-3'-fluoro-2-fluoroadenosine, 2',3'-dideoxy-3'-fluoro-6-thioguanosine, 2',3'-dideoxy-3'-fluoro-2,6-diaminopurineriboside, 2',3'-dideoxy-3'-fluoro-2-aminopurineriboside, 2',3'-dideoxy-3'-fluoro-5-aminomethyluridine, 2',3'-dideoxy-3'-fluoro-5-azidomethyluridine, and 2',3'-dideoxy-3'-fluoro-5-hydroxymethyluridine.
一种治疗艾滋病的方法,包括向需要该方法的患者给予含有以下化合物的药物组合物:##STR1## 其中:R.sub.1是腺嘌呤、胞嘧啶、鸟嘌呤、胸腺嘧啶、尿嘧啶、5-取代尿嘧啶、5-取代胞嘧啶衍生物、2-氟腺嘌呤、2,6-二氨基嘌呤、2-氨基嘌呤、6-硫代鸟嘌呤或7-去氮腺嘌呤基团;R.sub.2是氢或OH基团;R.sub.3是OH、O-酰基、O-棕榈酰基或磷酸盐(作为游离酸或其碱金属、铵或烷基铵盐)或羟基基团的任何其他前体基团;或其生理上可接受的盐。此外,本发明还包括以下新化合物:2',3'-二脱氧-3'-氟-2-氟腺苷、2',3'-二脱氧-3'-氟-6-硫代鸟苷、2',3'-二脱氧-3'-氟-2,6-二氨基嘌呤核苷、2',3'-二脱氧-3'-氟-2-氨基嘌呤核苷、2',3'-二脱氧-3'-氟-5-氨甲基尿苷、2',3'-二脱氧-3'-氟-5-叠氮甲基尿苷和2',3'-二脱氧-3'-氟-5-羟甲基尿苷。